Literature DB >> 18202888

Prevalence of dysphagia in patients with gastroesophageal reflux in Germany.

Elfriede Bollschweiler1, Katharina Knoppe, Eva Wolfgarten, Arnulf H Hölscher.   

Abstract

Dysphagia is an alarming symptom that raises the possibility of stricture or malignancy. This study compares the prevalence and severity of dysphagia symptoms in subjects with or without gastroesophageal reflux (GERD). In a population-based study, 500 residents of Cologne between the ages of 20 and 90 years [232 (46%) males and 268 (54%) females] were randomly selected from the city register and sent questionnaires with reflux-related questions. Two hundred sixty-eight replies (54%) were accepted into the study. Of these, 45% were men with a median age of 58 years. The median female age was 54 years. Thirty-four percent of the respondents (n=92) admitted having heartburn symptoms. There was no significant gender-based difference. There was little variation in reflux frequency between individual age groups. Twenty-three (25%) of the 92 respondents with reflux reported symptoms more than twice per week. Forty-five percent of this "reflux" group took medications for their heartburn. Swallowing difficulties, predominantly mild, were reported in 11.3% of the respondents. Dysphagia was significantly increased in the reflux group (28%) versus the normal group (3%) (p<0.001). Sixteen percent of respondents with mild and 65% of those with moderate to severe reflux symptoms reported additional dysphagia symptoms (p<0.001). Swallowing problems are common in patients with GERD. Approximately two thirds of patients with long-term and severe reflux symptoms also have dysphagia symptoms. Dysphagia should always be investigated by a physician.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18202888     DOI: 10.1007/s00455-007-9120-5

Source DB:  PubMed          Journal:  Dysphagia        ISSN: 0179-051X            Impact factor:   3.438


  24 in total

1.  Demographic variations in the rising incidence of esophageal adenocarcinoma in white males.

Authors:  E Bollschweiler; E Wolfgarten; C Gutschow; A H Hölscher
Journal:  Cancer       Date:  2001-08-01       Impact factor: 6.860

2.  Lifestyle factors and symptoms of gastro-oesophageal reflux -- a population-based study.

Authors:  M Nocon; J Labenz; S N Willich
Journal:  Aliment Pharmacol Ther       Date:  2006-01-01       Impact factor: 8.171

3.  Prevalence of dysphagia among community-dwelling elderly individuals as estimated using a questionnaire for dysphagia screening.

Authors:  Kei Kawashima; Yutaka Motohashi; Ichiro Fujishima
Journal:  Dysphagia       Date:  2004       Impact factor: 3.438

4.  Reflux rising! An essay on witnessing a disease in evolution.

Authors:  K D Bardhan; C Royston; A K Nayyar
Journal:  Dig Liver Dis       Date:  2005-11-16       Impact factor: 4.088

5.  Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population.

Authors:  J Isolauri; P Laippala
Journal:  Ann Med       Date:  1995-02       Impact factor: 4.709

6.  Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia.

Authors:  P Terry; J Lagergren; A Wolk; O Nyrén
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

7.  [Prevalence of gastro-oesophageal reflux disease in general practice].

Authors:  M Hollenz; M Stolte; J Labenz
Journal:  Dtsch Med Wochenschr       Date:  2002-05-10       Impact factor: 0.628

8.  The usefulness of a structured questionnaire in the assessment of symptomatic gastroesophageal reflux disease.

Authors:  R Carlsson; J Dent; E Bolling-Sternevald; F Johnsson; O Junghard; K Lauritsen; S Riley; L Lundell
Journal:  Scand J Gastroenterol       Date:  1998-10       Impact factor: 2.423

Review 9.  Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.

Authors:  Manuel Pera
Journal:  World J Surg       Date:  2003-08-18       Impact factor: 3.352

10.  Dysphagia in patients with erosive esophagitis: prevalence, severity, and response to proton pump inhibitor treatment.

Authors:  Nimish B Vakil; Barry Traxler; Douglas Levine
Journal:  Clin Gastroenterol Hepatol       Date:  2004-08       Impact factor: 11.382

View more
  7 in total

1.  Esophagus-Related Symptoms in First-Degree Relatives of Patients with Achalasia: Is Screening Necessary?

Authors:  Henning R Gockel; Moritz Lesse; Johannes Schumacher; Michaela Müller; Ines Gockel
Journal:  Visc Med       Date:  2016-08-17

2.  Prevalence and risk factors for dysphagia: a USA community study.

Authors:  S Y Cho; R S Choung; Y A Saito; C D Schleck; A R Zinsmeister; G R Locke; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2014-11-06       Impact factor: 3.598

3.  Central inhibition of initiation of swallowing by systemic administration of diazepam and baclofen in anaesthetized rats.

Authors:  Takanori Tsujimura; Shogo Sakai; Taku Suzuki; Izumi Ujihara; Kojun Tsuji; Jin Magara; Brendan J Canning; Makoto Inoue
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-03-02       Impact factor: 4.052

Review 4.  Surgical treatment of gastroesophageal reflux disease.

Authors:  Christian A Gutschow; Arnulf H Hölscher
Journal:  Langenbecks Arch Surg       Date:  2012-04-12       Impact factor: 3.445

5.  Comorbid Dysphagia and Dyspnea in Muscle Tension Dysphonia: A Global Laryngeal Musculoskeletal Problem.

Authors:  Patrick O McGarey; Nicholas A Barone; Michael Freeman; James J Daniero
Journal:  OTO Open       Date:  2018-08-24

Review 6.  Current Advancement on the Dynamic Mechanism of Gastroesophageal Reflux Disease.

Authors:  Zhi Zheng; Yuxi Shang; Ning Wang; Xiaoye Liu; Chenglin Xin; Xiaosheng Yan; Yuhao Zhai; Jie Yin; Jun Zhang; Zhongtao Zhang
Journal:  Int J Biol Sci       Date:  2021-10-03       Impact factor: 6.580

7.  Heartburn-Related Internet Searches and Trends of Interest across Six Western Countries: A Four-Year Retrospective Analysis Using Google Ads Keyword Planner.

Authors:  Mikołaj Kamiński; Igor Łoniewski; Agata Misera; Wojciech Marlicz
Journal:  Int J Environ Res Public Health       Date:  2019-11-20       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.